Epithelial cancers of the ovaries continue to be a major health problem in the United States. The American Cancer Society estimates that there will be about 23,400 new cases of ovarian cancer this year in the United States, and about 13,900 women will die of the disease. Ovarian cancer is currently the 6th most common cancer in the United States and the fourth most common cause of female cancer deaths, ranking behind lung, breast and colon cancer. Signs and symptoms of ovarian cancer usually don't present before the cancer has spread throughout the pelvis. Frequently the extent of the disease is not known until the initial surgery is performed. Additionally, there is a high rate of recurrence and monitoring with serum tumor markers is important.
How Does PET/CT make a Difference?
PET is by far the best imaging procedure for ovarian cancer patients, even better than direct visualization at laparotomy. PET can diagnose the primary tumor and the spread of the disease earlier in the course of the disease.
Staging with PET offers a more accurate diagnostic work-up and treatment plan.
Monitoring for recurrence and metastatic involvement with PET can take the place of a second-look surgical procedure.
For More Information
Find the support you need! Several organizations provide information and support to patients and their families, including the following:
For more information about the PET/CT scanner or to make an appointment, call the Division of Nuclear Medicine at (410) 328-6891.
This page was last updated: July 8, 2013